High-performance liquid chromatography of HIV protease inhibitors in human biological matrices
Authors:
- R.E AarnoutseRAR.E Aarnoutse
- C.P.W.G.M Verweij-Van WissenCWC.P.W.G.M Verweij-Van Wissen
- W.J.M UnderbergWUW.J.M Underberg
- J KleinnijenhuisJKJ Kleinnijenhuis
- Y.A HeksterYHY.A Hekster
- D.M BurgerDBD.M Burger
- 1 November 2001
- journal article
- review article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 764 (1-2) , 363-384
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Dual protease inhibitor therapy in the management of the HIV-1Expert Opinion on Pharmacotherapy, 2000
- Dose-Finding Study of Once-Daily Indinavir/Ritonavir Plus Zidovudine and Lamivudine in HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Rapid and Simple Determination of Indinavir in Serum, Urine, and Cerebrospinal Fluid Using High-Performance Liquid ChromatographyTherapeutic Drug Monitoring, 2000
- Saquinavir Soft-Gel CapsuleDrugs, 2000
- HIV-1 Protease InhibitorsClinical Infectious Diseases, 2000
- Using Pharmacokinetics to Optimize Antiretroviral Drug-Drug Interactions in the Treatment of Human Immunodeficiency Virus InfectionClinical Infectious Diseases, 2000
- NelfinavirDrugs, 2000
- Relationships Between Exposure to Saquinavir Monotherapy and Antiviral Response in HIV-Positive PatientsClinical Pharmacokinetics, 1999
- Pharmacokinetics and Potential Interactions Amongst Antiretroviral Agents Used To Treat Patients with HIV InfectionClinical Pharmacokinetics, 1999
- RitonavirClinical Pharmacokinetics, 1998